$191 Million is the total value of GREAT POINT PARTNERS LLC's 38 reported holdings in Q1 2014. The portfolio turnover from Q4 2013 to Q1 2014 was 100.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| FURX | Sell | FURIEX PHARMACEUTICALS INC | $17,910,000 | +33.4% | 205,858 | -35.6% | 9.35% | -1.3% |
| HPTX | Sell | HYPERION THERAPEUTICS INC | $12,739,000 | -22.3% | 493,751 | -39.1% | 6.65% | -42.6% |
| PTIE | Sell | PAIN THERAPEUTICS INC | $12,580,000 | -7.5% | 2,287,279 | -18.2% | 6.57% | -31.6% |
| ALIM | New | ALIMERA SCIENCES INC | $11,835,000 | – | 1,500,000 | +100.0% | 6.18% | – |
| DSCI | New | DERMA SCIENCES INC | $11,729,000 | – | 925,000 | +100.0% | 6.12% | – |
| OXBT | New | OXYGEN BIOTHERAPEUTICS INC | $11,100,000 | – | 2,000,000 | +100.0% | 5.80% | – |
| NBIX | New | NEUROCRINE BIOSCIENCES INC | $9,982,000 | – | 620,000 | +100.0% | 5.21% | – |
| OFIX | New | ORTHOFIX INTL N Vput | $7,990,000 | – | 265,000 | +100.0% | 4.17% | – |
| OFIX | New | ORTHOFIX INTL N V | $7,538,000 | – | 250,000 | +100.0% | 3.94% | – |
| AMBI | Sell | AMBIT BIOSCIENCES CORP | $6,560,000 | -7.1% | 719,261 | -1.8% | 3.43% | -31.3% |
| INFI | Buy | INFINITY PHARMACEUTICALS INC | $5,950,000 | -4.5% | 500,400 | +10.9% | 3.11% | -29.4% |
| 5100PS | Buy | VOLCANO CORPORATION | $5,913,000 | +35.3% | 300,000 | +50.0% | 3.09% | +0.1% |
| ADHD | Buy | ALCOBRA LTD | $5,329,000 | +18.4% | 293,610 | +17.4% | 2.78% | -12.4% |
| VCYT | Sell | VERACYTE INC | $5,315,000 | +3.6% | 310,248 | -12.3% | 2.78% | -23.4% |
| SPHS | Buy | SOPHIRIS BIO INC | $4,995,000 | -2.2% | 1,500,000 | +8.7% | 2.61% | -27.6% |
| ANTH | New | ANTHERA PHARMACEUTICALS INC | $4,587,000 | – | 1,369,237 | +100.0% | 2.40% | – |
| AVEO | Sell | AVEO PHARMACEUTICALS INC | $4,285,000 | -21.9% | 2,866,483 | -4.5% | 2.24% | -42.3% |
| REPH | New | RECRO PHARMA INC | $4,246,000 | – | 580,000 | +100.0% | 2.22% | – |
| SSH | Sell | SUNSHINE HEART INC | $4,246,000 | -52.3% | 727,000 | -20.6% | 2.22% | -64.7% |
| PLX | Sell | PROTALIX BIOTHERAPEUTICS INC | $4,178,000 | +7.4% | 912,155 | -8.8% | 2.18% | -20.6% |
| CARA | New | CARA THERAPEUTICS INC | $3,314,000 | – | 178,065 | +100.0% | 1.73% | – |
| OCRX | Sell | OCERA THERAPEUTICS INC | $3,290,000 | -52.0% | 311,821 | -40.9% | 1.72% | -64.5% |
| CYTK | New | CYTOKINETICS INC | $2,993,000 | – | 315,000 | +100.0% | 1.56% | – |
| ONTY | New | ONCOTHYREON INC | $2,965,000 | – | 991,800 | +100.0% | 1.55% | – |
| NSPH | Sell | NANOSPHERE INC | $2,753,000 | -51.9% | 1,280,309 | -48.8% | 1.44% | -64.4% |
| DPRX | New | DIPEXIUM PHARMACEUTICALS INC | $2,520,000 | – | 250,000 | +100.0% | 1.32% | – |
| MNKD | New | MANNKIND CORP | $2,199,000 | – | 546,900 | +100.0% | 1.15% | – |
| MNKD | New | MANNKIND CORPcall | $2,119,000 | – | 527,000 | +100.0% | 1.11% | – |
| MEIP | MEI PHARMA INC | $1,755,000 | +39.0% | 157,661 | 0.0% | 0.92% | +2.8% | |
| CCXI | Sell | CHEMOCENTRYX INC | $1,656,000 | -71.4% | 249,700 | -75.0% | 0.86% | -78.8% |
| OGXI | New | ONCOGENEX PHARMACEUTICALS INcall | $1,529,000 | – | 130,000 | +100.0% | 0.80% | – |
| KBIO | New | KALOBIOS PHARMACEUTICALS INC | $1,455,000 | – | 536,894 | +100.0% | 0.76% | – |
| SNSS | New | SUNESIS PHARMACEUTICALS INC | $1,279,000 | – | 193,567 | +100.0% | 0.67% | – |
| PSDV | Sell | PSIVIDA CORP | $1,162,000 | -41.5% | 283,313 | -43.3% | 0.61% | -56.7% |
| STRM | Buy | STREAMLINE HEALTH SOLUTIONS | $763,000 | +30.2% | 151,611 | +80.6% | 0.40% | -3.9% |
| MNTA | New | MOMENTA PHARMACEUTICALS INC | $722,000 | – | 62,000 | +100.0% | 0.38% | – |
| WMGIZ | Exit | WRIGHT MED GROUP INCright 03/01/2019 | $0 | – | -116,600 | -100.0% | -0.03% | – |
| RMTI | Exit | ROCKWELL MED INC | $0 | – | -40,000 | -100.0% | -0.30% | – |
| MSTX | Exit | MAST THERAPEUTICS INC | $0 | – | -1,294,934 | -100.0% | -0.42% | – |
| CBMX | Exit | COMBIMATRIX CORPORATION | $0 | – | -369,075 | -100.0% | -0.60% | – |
| AVNR | Exit | AVANIR PHARMACEUTICALS INCcall | $0 | – | -567,000 | -100.0% | -1.34% | – |
| CHTP | Exit | CHELSEA THERAPEUTICS INTL LTput | $0 | – | -726,800 | -100.0% | -2.28% | – |
| HZNP | Exit | HORIZON PHARMA INC | $0 | – | -500,000 | -100.0% | -2.69% | – |
| HTWR | Exit | HEARTWARE INTL INC | $0 | – | -46,795 | -100.0% | -3.10% | – |
| CYNO | Exit | CYNOSURE INCcl a | $0 | – | -170,000 | -100.0% | -3.20% | – |
| AERI | Exit | AERIE PHARMACEUTICALS INC. | $0 | – | -308,429 | -100.0% | -3.91% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2014-05-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| STREAMLINE HEALTH SOLUTNS, INC CMN | 25 | Q3 2019 | 2.5% |
| IOVANCE BIOTHERAPEUTICS, INC. CMN | 16 | Q1 2021 | 14.3% |
| ZOGENIX INC CMN | 16 | Q4 2019 | 8.8% |
| PTC THERAPEUTICS, INC. CMN | 16 | Q3 2023 | 9.9% |
| EXELIXIS, INC | 16 | Q1 2022 | 7.5% |
| SAGE THERAPEUTICS, INC CMN | 15 | Q3 2021 | 10.8% |
| CYTOKINETICS INC | 15 | Q3 2023 | 5.8% |
| ACADIA PHARMACEUTICALS, INC. | 14 | Q1 2021 | 8.8% |
| ACCELERON PHARMA INC CMN | 14 | Q2 2020 | 8.2% |
| CONNECTURE INC | 13 | Q4 2017 | 25.1% |
View GREAT POINT PARTNERS LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| 89bio, Inc. | February 14, 2023 | 700,000 | 1.4% |
| KalVista Pharmaceuticals, Inc. | February 14, 2023 | 1,055,801 | 3.1% |
| Avalo Therapeutics, Inc. | February 13, 2023 | 974,639 | 7.1% |
| InflaRx N.V.Sold out | February 14, 2022 | 0 | 0.0% |
| ABEONA THERAPEUTICS INC.Sold out | February 16, 2021 | 0 | 0.0% |
| CONSTELLATION PHARMACEUTICALS INC | February 16, 2021 | 1,024,800 | 2.2% |
| GERON CORP | February 16, 2021 | 12,754,228 | 4.0% |
| Millendo Therapeutics, Inc. | February 16, 2021 | 270,000 | 1.4% |
| NextCure, Inc.Sold out | February 16, 2021 | 0 | 0.0% |
| PROTHENA CORP PUBLIC LTD CO | February 16, 2021 | 977,647 | 2.4% |
View GREAT POINT PARTNERS LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G | 2024-04-08 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
View GREAT POINT PARTNERS LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.